Therefore, the expression levels of VE-cadherin, ZO-1 and Claudin 5 were measured after a 48-h treatment with EEVs derived from erythrocyte samples of age and sex-matched healthy controls, or from PD patients diagnosed with mild or severe clinical symptoms. This evidence concerns the gene CLDN5 and Parkinson disease.